Clinical benefit of pemafibrate in patients with primary biliary cholangitis (PBC) with dyslipidemia
Not Applicable
- Conditions
- primary biliary cholangitis
- Registration Number
- JPRN-UMIN000039350
- Lead Sponsor
- Shinshu University Faculty of Medicine, Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Exclude patients who meet the following criteria 1) Patients who have already taken pemafibrate 2) Preexisting disorders of being allergic to pemafibrate 3) Pregnant women or breast-feeding women 4) Patients who have already taken statins. 5) Patients by whom principal investigator has determined to be inappropriate as a subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum ALP, GGT, AST, ALT, T-Bil, T-chol, HDL-chol, TG levels in 12 months.
- Secondary Outcome Measures
Name Time Method